1. Home
  2. DIOD vs HRMY Comparison

DIOD vs HRMY Comparison

Compare DIOD & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DIOD
  • HRMY
  • Stock Information
  • Founded
  • DIOD 1959
  • HRMY 2017
  • Country
  • DIOD United States
  • HRMY United States
  • Employees
  • DIOD N/A
  • HRMY N/A
  • Industry
  • DIOD Semiconductors
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • DIOD Technology
  • HRMY Health Care
  • Exchange
  • DIOD Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • DIOD 2.2B
  • HRMY 2.0B
  • IPO Year
  • DIOD N/A
  • HRMY 2020
  • Fundamental
  • Price
  • DIOD $55.38
  • HRMY $31.95
  • Analyst Decision
  • DIOD Buy
  • HRMY Strong Buy
  • Analyst Count
  • DIOD 2
  • HRMY 9
  • Target Price
  • DIOD $57.50
  • HRMY $54.22
  • AVG Volume (30 Days)
  • DIOD 518.3K
  • HRMY 661.5K
  • Earning Date
  • DIOD 08-07-2025
  • HRMY 08-05-2025
  • Dividend Yield
  • DIOD N/A
  • HRMY N/A
  • EPS Growth
  • DIOD N/A
  • HRMY 13.13
  • EPS
  • DIOD 0.55
  • HRMY 2.62
  • Revenue
  • DIOD $1,341,261,000.00
  • HRMY $744,852,000.00
  • Revenue This Year
  • DIOD $10.90
  • HRMY $20.10
  • Revenue Next Year
  • DIOD $7.36
  • HRMY $18.01
  • P/E Ratio
  • DIOD $100.59
  • HRMY $12.20
  • Revenue Growth
  • DIOD N/A
  • HRMY 20.62
  • 52 Week Low
  • DIOD $32.93
  • HRMY $26.47
  • 52 Week High
  • DIOD $86.74
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • DIOD 70.07
  • HRMY 44.85
  • Support Level
  • DIOD $51.58
  • HRMY $31.25
  • Resistance Level
  • DIOD $53.53
  • HRMY $32.32
  • Average True Range (ATR)
  • DIOD 1.38
  • HRMY 0.98
  • MACD
  • DIOD 0.08
  • HRMY -0.19
  • Stochastic Oscillator
  • DIOD 100.00
  • HRMY 21.37

About DIOD Diodes Incorporated

Diodes Inc is a manufacturer and supplier of high-quality application-specific products within the broad discrete, logic, analog, and mixed-signal semiconductor markets. It serves the customer electronics, computing, communications, industrial, and automotive markets. The Company's products include diodes; rectifiers; transistors; MOSFETs; GPP bridges; GPP rectifiers; protection devices; function-specific arrays; single gate logic; amplifiers and comparators; Hall-effect and temperature sensors; and power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, voltage references along with special-function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: